Covid-19 'Cure' statement 'disingenuous', Vital Knowledge says

• Vital Knowledge Media joined Stat's Adam Feuerstein in voicing skepticism over Friday's announcement that Sorrento Therapeutics (NASDAQ:SRNE) had discovered an antibody, dubbed STI-1499, that, it says, can provide 100% inhibition of SARS-CoV-2.
• The co. indicated then that their discovery could be "more effective" than a vaccine.
• The statement Friday was "very disingenuous" on their part, and, generally, "some of the narratives around drugs and vaccines" need to be tempered, Adam Crisafulli of Vital Knowledge said, highlighting concerns about timing, coming to market and distribution and immunity through the population.
• Shares of Sorrento, meanwhile, are up another 40% this morning after soaring 150% on Friday.
• Another name seeking a vaccine, Moderna (NASDAQ:MRNA), earlier disclosed preliminary results about their vaccine candidate, and shares there are up 28% pre-market.
• Read more about how some SA contributors are playing this theme.